Walleye Capital LLC Buys 5,408 Shares of Teleflex Incorporated (NYSE:TFX)

Walleye Capital LLC boosted its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 420.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,695 shares of the medical technology company's stock after purchasing an additional 5,408 shares during the period. Walleye Capital LLC's holdings in Teleflex were worth $1,192,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Barclays PLC boosted its position in Teleflex by 1.6% during the 3rd quarter. Barclays PLC now owns 89,907 shares of the medical technology company's stock worth $22,233,000 after buying an additional 1,426 shares during the period. Sanctuary Advisors LLC increased its holdings in Teleflex by 9.8% in the third quarter. Sanctuary Advisors LLC now owns 4,877 shares of the medical technology company's stock worth $1,206,000 after purchasing an additional 437 shares in the last quarter. Wilmington Savings Fund Society FSB increased its stake in shares of Teleflex by 6.3% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 27,759 shares of the medical technology company's stock valued at $6,865,000 after acquiring an additional 1,647 shares in the last quarter. Tidal Investments LLC raised its holdings in shares of Teleflex by 29.7% during the third quarter. Tidal Investments LLC now owns 8,014 shares of the medical technology company's stock valued at $1,982,000 after purchasing an additional 1,837 shares during the period. Finally, Franklin Resources Inc. raised its stake in Teleflex by 64.3% during the 3rd quarter. Franklin Resources Inc. now owns 9,683 shares of the medical technology company's stock worth $2,298,000 after buying an additional 3,790 shares during the period. Institutional investors and hedge funds own 95.62% of the company's stock.

Analyst Upgrades and Downgrades

TFX has been the subject of a number of analyst reports. Citizens Jmp downgraded Teleflex from an "outperform" rating to a "market perform" rating in a research note on Thursday, February 27th. Royal Bank of Canada downgraded shares of Teleflex from an "outperform" rating to a "sector perform" rating and decreased their price objective for the stock from $220.00 to $155.00 in a report on Friday, February 28th. Piper Sandler restated a "neutral" rating and issued a $140.00 target price (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. StockNews.com lowered shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a report on Wednesday, March 12th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $169.63.

Teleflex Price Performance

NYSE TFX traded up $2.42 during trading hours on Thursday, reaching $135.44. 487,728 shares of the stock traded hands, compared to its average volume of 627,676. The company has a market cap of $6.28 billion, a price-to-earnings ratio of 26.93, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a 1 year low of $124.66 and a 1 year high of $249.91. The stock has a 50 day simple moving average of $141.49 and a two-hundred day simple moving average of $175.69.

Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating the consensus estimate of $3.86 by $0.03. The company had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. On average, analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 1.00%. Teleflex's dividend payout ratio is currently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.